These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4199524

  • 21. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
    Miyamura S.
    Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Methylprednisolone in pulsed doses in chronic glomerulopathies and in nephrotic syndrome with minimal change].
    Matousovic K, Prát V, Kuzemová L, Zástava V.
    Vnitr Lek; 1988 Mar; 34(3):262-9. PubMed ID: 3369099
    [No Abstract] [Full Text] [Related]

  • 27. Fibrin degradation products and complement in glomerulonephritis.
    Szewczyk Z, Ratajczak T, Melcer H, Skurzewski J, Skurzewska A.
    Proc Eur Dial Transplant Assoc; 1973 Mar; 10(0):531-7. PubMed ID: 4802477
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
    Clarkson AR, MacDonald MK, Petrie JJ, Cash JD, Robson JS.
    Br Med J; 1971 Aug; 3(5772):447-51. PubMed ID: 5567767
    [Abstract] [Full Text] [Related]

  • 34. [Indomethacin in the treatment of glomerulonephritis].
    Tomilina NA, Biriukova LS.
    Sov Med; 1983 Aug; (9):104-6. PubMed ID: 6648668
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states.
    Sanchez-Avalos J, Miller SP.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):499-515. PubMed ID: 4974324
    [No Abstract] [Full Text] [Related]

  • 37. [Comparative study of urine immunoelectrophoresis and 4 indexes of glomerular selectivity in chronic glomerulopathies].
    Cahen R, François B, Sabot JF, Bernard P, Picq JP, Adeleine P.
    Pathol Biol (Paris); 1985 Jan 31; 33(1):23-6. PubMed ID: 3975073
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Urinary crosslinked fibrin degradation products in glomerular disease.
    Kamitsuji H, Whitworth JA, Dowling JP, Kincaid-Smith P.
    Am J Kidney Dis; 1986 Jun 31; 7(6):452-5. PubMed ID: 3717150
    [Abstract] [Full Text] [Related]

  • 40. Fibrinuria during renal transplantation.
    Antoine B, Neveu T, Ward PD.
    Transplantation; 1969 Aug 31; 8(2):98-109. PubMed ID: 4979693
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.